Ten-year follow-up of a prospective trial for the targeted therapy of gastric cancer with the human monoclonal antibody PAT-SC1.

Oncol Rep · 2014 · PMC3926647 · PMID 24452482

Europe PMC DOI

hedged sentence

0.2270

closest p · 4.5× alpha

0.2270

boldest claim

The sentences

did not reach statistical significancep=0.227not close (p > 0.1)

The data indicate that the expression of CD55 PAT-SC1 had a trend toward a correlation with poorer survival but did not reach statistical significance with the number of patients studied (p=0.227).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.